ERβ promotes NSCLC invasion and migration by upregulating TLR4 expression and activating the downstream myeloid differentiation factor 88 (myd88)–nuclear factor-κB (NF-κB)–matrix metalloproteinase-2 (MMP-2) signaling axis [58]. The gene discussed is ESR2; the disease is non-small cell lung carcinoma.